CMBA
BIO icon

C.M. Bidwell & Associates’s Bio-Rad Laboratories Class A BIO Stock Holding History

C.M. Bidwell & Associates’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-895
Closed -$280K – 396
2018
Q3 		$280K Sell
895
-215
-19% -$66.7K 0.27% 103
2018
Q2 		$320K Sell
1,110
-2,410
-68% -$665K 0.3% 92
2018
Q1 		$880K Buy
+3,520
New +$896K 0.81% 29
2017
Q4 		– Sell
-160
Closed -$36K – 401
2017
Q3 		$36K Sell
160
-19,075
-99% -$4.29M 0.06% 183
2017
Q2 		$4.35M Sell
19,235
-3,290
-15% -$717K 0.93% 44
2017
Q1 		$4.49M Sell
22,525
-30
-0.1% -$5.78K 1.01% 31
2016
Q4 		$4.11M Buy
+22,555
New +$3.85M 0.97% 38
2016
Q3 		– Sell
-1,935
Closed -$277K – 259
2016
Q2 		$277K Buy
+1,935
New +$276K 0.07% 130

Other funds holding BIO

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $501B AUM 22.01% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.31B AUM 28.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return